Medicine & Life Sciences
Mantle-Cell Lymphoma
100%
Rituximab
96%
Follicular Lymphoma
58%
Bendamustine Hydrochloride
44%
PCI 32765
35%
Bortezomib
35%
Lymphoma, Large B-Cell, Diffuse
34%
Allogeneic Cells
30%
Progression-Free Survival
30%
Stem Cell Transplantation
30%
Lymphoma
23%
Survival
21%
Agammaglobulinaemia Tyrosine Kinase
21%
Hodgkin Disease
19%
Cytarabine
19%
Mitoxantrone
14%
fludarabine
14%
Geriatric Assessment
14%
Vincristine
14%
Systemic Mastocytosis
14%
Ovarian Teratoma
13%
Prednisone
13%
Blast Crisis
13%
Elderly
12%
Cyclophosphamide
12%
Mycosis Fungoides
12%
Philadelphia Chromosome
12%
Epirubicin
12%
Vinblastine
11%
Teratoma
10%
Doxorubicin
10%
Lymphocyte Count
10%
B-Cell Chronic Lymphocytic Leukemia
10%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10%
B-Cell Lymphoma
9%
Chimeric Antigen Receptors
9%
Therapeutics
9%
Cytogenetics
9%
Mast Cells
9%
Italy
9%
Positron-Emission Tomography
8%
Dexamethasone
8%
Monocytes
7%
Neutropenia
7%
Leukemia
7%
Graft vs Host Disease
7%
Emotions
7%
Mortality
7%
Prospective Studies
7%
Observation
6%